A director at a Chester-based architectural, building surveying and planning consultancy has been appointed monitoring surveyor for a new laboratory in Liverpool to research resistance to antibiotics.

David Owen, of Cassidy and Ashton, will oversee the project for the new £25m Liverpool Life Sciences Accelerator and report to investors, which include The Chrysalis Fund, The Royal Liverpool University and Broadgreen Hospitals Trust (RLBUHT) and Liverpool School of Tropical Medicine (LSTM), to ensure the scheme remains viable.

The five-floor state-of-the-art facility, situated within the grounds of the Royal Liverpool University Hospital, will provide laboratory space and offices across 70,000 sq ft It is expected to open in June 2017.

A CGI of the Liverpool Life Sciences Accelerator

Developed in partnership with the LSTM and the RLBUH scientists at the centre will research resistance to antibiotics.

Director of the School Professor Janet Hemingway said: “LSTM was one of the first institutions in the world to recognise the importance of studying and understanding the phenomenon of drug resistance. The accelerator will allow us to further boost Liverpool’s reputation as a world renowned centre of expertise.”

David Owen said: “Whilst the position of monitoring surveyor is becoming more common in today’s competitive market, it is an honour to have been appointed to such a prestigious project.

“Building work is already well underway and I, along with many others, will be reviewing the projects progress until it comes to practical completion.”